Literature DB >> 18268027

Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates.

Takafumi Tsuboi1, Satoru Takeo, Hideyuki Iriko, Ling Jin, Masateru Tsuchimochi, Shusaku Matsuda, Eun-Taek Han, Hitoshi Otsuki, Osamu Kaneko, Jetsumon Sattabongkot, Rachanee Udomsangpetch, Tatsuya Sawasaki, Motomi Torii, Yaeta Endo.   

Abstract

One of the major bottlenecks in malaria research has been the difficulty in recombinant protein expression. Here, we report the application of the wheat germ cell-free system for the successful production of malaria proteins. For proof of principle, the Pfs25, PfCSP, and PfAMA1 proteins were chosen. These genes contain very high A/T sequences and are also difficult to express as recombinant proteins. In our wheat germ cell-free system, native and codon-optimized versions of the Pfs25 genes produced equal amounts of proteins. PfCSP and PfAMA1 genes without any codon optimization were also expressed. The products were soluble, with yields between 50 and 200 mug/ml of the translation mixture, indicating that the cell-free system can be used to produce malaria proteins without any prior optimization of their biased codon usage. Biochemical and immunocytochemical analyses of antibodies raised in mice against each protein revealed that every antibody retained its high specificity to the parasite protein in question. The development of parasites in mosquitoes fed patient blood carrying Plasmodium falciparum gametocytes and supplemented with our mouse anti-Pfs25 sera was strongly inhibited, indicating that both Pfs25-3D7/WG and Pfs25-TBV/WG retained their immunogenicity. Lastly, we carried out a parallel expression assay of proteins of blood-stage P. falciparum. The PCR products of 124 P. falciparum genes chosen from the available database were used directly in a small-scale format of transcription and translation reactions. Autoradiogram testing revealed the production of 93 proteins. The application of this new cell-free system-based protocol for the discovery of malaria vaccine candidates will be discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268027      PMCID: PMC2292889          DOI: 10.1128/IAI.01539-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Cell-free protein production and labeling protocol for NMR-based structural proteomics.

Authors:  Dmitriy A Vinarov; Betsy L Lytle; Francis C Peterson; Ejan M Tyler; Brian F Volkman; John L Markley
Journal:  Nat Methods       Date:  2004-10-21       Impact factor: 28.547

2.  Selection of 5'-untranslated sequences that enhance initiation of translation in a cell-free protein synthesis system from wheat embryos.

Authors:  Nami Kamura; Tatsuya Sawasaki; Yuko Kasahara; Kazuyuki Takai; Yaeta Endo
Journal:  Bioorg Med Chem Lett       Date:  2005-10-05       Impact factor: 2.823

Review 3.  Cell-free expression systems for eukaryotic protein production.

Authors:  Yaeta Endo; Tatsuya Sawasaki
Journal:  Curr Opin Biotechnol       Date:  2006-07-07       Impact factor: 9.740

4.  Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes.

Authors:  Christopher Mehlin; Erica Boni; Frederick S Buckner; Linnea Engel; Tiffany Feist; Michael H Gelb; Lutfiyah Haji; David Kim; Colleen Liu; Natascha Mueller; Peter J Myler; J T Reddy; Joshua N Sampson; E Subramanian; Wesley C Van Voorhis; Elizabeth Worthey; Frank Zucker; Wim G J Hol
Journal:  Mol Biochem Parasitol       Date:  2006-04-18       Impact factor: 1.759

5.  The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases.

Authors:  John Samuelson; Sulagna Banerjee; Paula Magnelli; Jike Cui; Daniel J Kelleher; Reid Gilmore; Phillips W Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

6.  Refolding, purification, and crystallization of apical membrane antigen 1 from Plasmodium falciparum.

Authors:  Aditi Gupta; Tao Bai; Vince Murphy; Phillip Strike; Robin F Anders; Adrian H Batchelor
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

7.  Progress towards the development of malaria vaccines.

Authors:  Elissa Malkin; Filip Dubovsky; Melinda Moree
Journal:  Trends Parasitol       Date:  2006-05-16

8.  Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.

Authors:  Takeshi Arakawa; Ai Komesu; Hitoshi Otsuki; Jetsumon Sattabongkot; Rachanee Udomsangpetch; Yasunobu Matsumoto; Naotoshi Tsuji; Yimin Wu; Motomi Torii; Takafumi Tsuboi
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

9.  Apical expression of three RhopH1/Clag proteins as components of the Plasmodium falciparum RhopH complex.

Authors:  Osamu Kaneko; Brian Y S Yim Lim; Hideyuki Iriko; Irene T Ling; Hitoshi Otsuki; Munira Grainger; Takafumi Tsuboi; John H Adams; Denise Mattei; Anthony A Holder; Motomi Torii
Journal:  Mol Biochem Parasitol       Date:  2005-09       Impact factor: 1.759

10.  The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion.

Authors:  Alida Coppi; Consuelo Pinzon-Ortiz; Christina Hutter; Photini Sinnis
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

View more
  94 in total

Review 1.  Systems immunology of human malaria.

Authors:  Tuan M Tran; Babru Samal; Ewen Kirkness; Peter D Crompton
Journal:  Trends Parasitol       Date:  2012-05-15

Review 2.  Cell-free protein synthesis: applications come of age.

Authors:  Erik D Carlson; Rui Gan; C Eric Hodgman; Michael C Jewett
Journal:  Biotechnol Adv       Date:  2011-10-08       Impact factor: 14.227

3.  Enzymatic characterization of the Plasmodium vivax chitinase, a potential malaria transmission-blocking target.

Authors:  Satoru Takeo; Daisuke Hisamori; Shusaku Matsuda; Joseph Vinetz; Jetsumon Sattabongkot; Takafumi Tsuboi
Journal:  Parasitol Int       Date:  2009-05-08       Impact factor: 2.230

4.  Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Authors:  R Zichel; A Mimran; A Keren; A Barnea; I Steinberger-Levy; D Marcus; A Turgeman; S Reuveny
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

5.  Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.

Authors:  Yang Cheng; Bo Wang; Jetsumon Sattabongkot; Chae Seung Lim; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2014-04-25       Impact factor: 2.289

6.  Expression of functional Plasmodium falciparum enzymes using a wheat germ cell-free system.

Authors:  Devaraja G Mudeppa; Pradipsinh K Rathod
Journal:  Eukaryot Cell       Date:  2013-10-11

7.  Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission.

Authors:  Hirokazu Sakamoto; Satoru Takeo; Eizo Takashima; Kazutoyo Miura; Bernard N Kanoi; Takamasa Kaneko; Eun-Taek Han; Mayumi Tachibana; Kazuhiro Matsuoka; Jetsumon Sattabongkot; Rachanee Udomsangpetch; Tomoko Ishino; Takafumi Tsuboi
Journal:  Parasitol Int       Date:  2017-12-05       Impact factor: 2.230

8.  Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax.

Authors:  Bo Wang; Feng Lu; Yang Cheng; Jian Li; Daisuke Ito; Jetsumon Sattabongkot; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2012-10-25       Impact factor: 2.289

9.  Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.

Authors:  Kazutoyo Miura; Eizo Takashima; Bingbing Deng; Gregory Tullo; Ababacar Diouf; Samuel E Moretz; Daria Nikolaeva; Mahamadou Diakite; Rick M Fairhurst; Michael P Fay; Carole A Long; Takafumi Tsuboi
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

10.  Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.

Authors:  K Vaughan; M Blythe; J Greenbaum; Q Zhang; B Peters; D L Doolan; A Sette
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.